Back to Search
GEORGE DEMETRI, MD
MD
Medical Oncology Physician
NPI: 1841267093IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
55911(MA)
Education
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Class of 1983
Research & Publications (20)
Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors.
PMID 19451435·J Clin Oncol·2009
3-trial
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.
PMID 19652065·J Clin Oncol·2009
3-trial
Structural reengineering of imatinib to decrease cardiac risk in cancer therapy.
PMID 18060025·J Clin Invest·2007
7-preclinical
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.
PMID 17046465·Lancet·2006
4-observational
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 32-2004. A 68-year-old man with a large retroperitoneal mass.
PMID 15496628·N Engl J Med·2004
5-case
Targeting the molecular pathophysiology of gastrointestinal stromal tumors with imatinib. Mechanisms, successes, and challenges to rational drug development.
PMID 12512386·Hematol Oncol Clin North Am·2002
5-case
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.
PMID 12181401·N Engl J Med·2002
3-trial
Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571).
PMID 12528773·Eur J Cancer·2002
6-review
Benefits of epoetin alfa in anemic breast cancer patients receiving chemotherapy.
PMID 12020395·Clin Breast Cancer·2002
8-other
Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options.
PMID 11740803·Semin Oncol·2001
6-review
Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy.
PMID 11308272·Br J Cancer·2001
6-review
Pharmacologic treatment options in patients with thrombocytopenia.
PMID 10831284·Semin Hematol·2000
6-review
Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib.
PMID 19326424·Pediatr Blood Cancer·2009
8-other
Therapeutic monitoring of drug plasma concentrations and improved clinical outcomes in GIST.
PMID 19391310·Clin Adv Hematol Oncol·2009
8-other
Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.
PMID 19451429·J Clin Oncol·2009
3-trial
Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma.
PMID 19647426·Eur J Cancer·2009
4-observational
Gastrointestinal stromal tumors II: medical oncology and tumor response assessment.
PMID 19664491·Semin Oncol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 450 BROOKLINE AVE, DFCI, D1212
BOSTON, MA 02215 - Phone
- (617) 632-3985
Quick Facts
- NPI
- 1841267093
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile